Search research articles
Contact Us
Filters
Showing results (291-300 of 401) with videos related to
Page
of 41
Sort By:
Human Gene Therapy
|
May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
Colin J D Ross, Jaap Twisk, Andrew C Bakker, et al.
European Heart Journal
|
October 21, 2019
A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor
Antoine Rimbert, Nawar Dalila, Justina C Wolters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 2, 2018
Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans
Federico Oldoni, Julian C van Capelleveen, Nawar Dalila, et al.
Trials
|
March 30, 2013
Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial
Amine Karimi, Sanne W de Boer, Daniël A F van den Heuvel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 2, 2012
Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations
Adriaan G Holleboom, Georgios Daniil, Xiaoming Fu, et al.
Journal of the American College of Cardiology
|
March 5, 2004
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy
Greetje J de Grooth, Kim E Zerba, Shu-Pang Huang, et al.
Journal of Lipid Research
|
May 8, 2013
In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1
Adriaan G Holleboom, Lily Jakulj, Remco Franssen, et al.
Cardiovascular Research
|
November 21, 2025
Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational upregulation of SR-B1 protein levels
Boyan Zhang, Natalia Loaiza, Antoine Rimbert, et al.
Journal of the American College of Cardiology
|
October 7, 2004
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
G Kees Hovingh, Alison Brownlie, Radjesh J Bisoendial, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 20, 2008
Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients
Erik S Stroes, Melchior C Nierman, Janneke J Meulenberg, et al.
Page
of 41
Search research articles
Search
Showing results (291-300 of 401) with videos related to
Sort By:
Page
of 41
Human Gene Therapy
|
May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
Colin J D Ross, Jaap Twisk, Andrew C Bakker, et al.
European Heart Journal
|
October 21, 2019
A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor
Antoine Rimbert, Nawar Dalila, Justina C Wolters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 2, 2018
Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans
Federico Oldoni, Julian C van Capelleveen, Nawar Dalila, et al.
Trials
|
March 30, 2013
Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial
Amine Karimi, Sanne W de Boer, Daniël A F van den Heuvel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 2, 2012
Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations
Adriaan G Holleboom, Georgios Daniil, Xiaoming Fu, et al.
Journal of the American College of Cardiology
|
March 5, 2004
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy
Greetje J de Grooth, Kim E Zerba, Shu-Pang Huang, et al.
Journal of Lipid Research
|
May 8, 2013
In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1
Adriaan G Holleboom, Lily Jakulj, Remco Franssen, et al.
Cardiovascular Research
|
November 21, 2025
Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational upregulation of SR-B1 protein levels
Boyan Zhang, Natalia Loaiza, Antoine Rimbert, et al.
Journal of the American College of Cardiology
|
October 7, 2004
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
G Kees Hovingh, Alison Brownlie, Radjesh J Bisoendial, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 20, 2008
Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients
Erik S Stroes, Melchior C Nierman, Janneke J Meulenberg, et al.
Page
of 41